| 13:30 - 14:00 |
Congress Hall
|
Keynote
Lecture 2 |
|
|
|
Chair: P. Krepelka (Czech Rep.) |
|
|
|
|
|
|
|
Risk of DVT with new molecules - Ø.
Lidegaard (Denmark) |
|
|
|
|
|
| 14:00 - 15:30 |
Congress Hall |
Sponsored
Symposium 4 (Bayer Schering Pharma): New research:
important data for counselling your OC patients |
|
|
|
Chair: M. Cronin (Bayer Schering Pharma) |
|
|
|
|
|
|
|
Bayer Schering Pharma: Taking a leading role in woman´s
health research - M. Cronin (Bayer Schering Pharma) |
|
|
|
EURAS: the largest European active surveillance study on
the safety and efficacy of OC us - J. Dinger (Germany |
|
|
|
Two new major studies on the protective effect of OC use
on ovarian and endometrial cancer - TBD |
|
|
|
Putting the new data into perspective for your OC patient
- L. Shulman (USA) |
|
|
|
|
|
|
|
|
|
| 14:00 - 15:30 |
Meeting Hall I
|
Congress
session 5: Induced abortion - An update |
|
|
|
Chair: V. Prilepskaya (Russia) - J. Bitzer
(Switzerland) |
|
|
|
|
Book of abstracts |
|
14:00 |
The challenge of post-abortion contraception - K.
Gemzell (Sweden) |
IS-53 |
|
14:20 |
Follow-up after induced abortion: current practice and
evidence - C. Fiala (Austria) |
IS-54 |
|
14:40 |
Access to safe abortion: legal and other obstacles
- M. Vekemans (United Kingdom) |
IS-55 |
|
15:00 |
A comparison of two dosages of buccal Misoprostol®
following Mifepristone® for early medical abortion - T. Tsereteli
(Georgia) |
FC-35 |
|
15:15 |
Expanding options for in-the-mouth Misoprostol®
administration following Mifepristone® in medical abortion - B.
Winikoff (USA) |
FC-36 |
|
|
|
|
| 14:00 - 15:30 |
Panorama Hall
|
|
|
|
14:00 |
Late Breaking News |
|
|
|
Estetrol: a new estrogen in the pill? - H.
Coelingh Bennink (The Netherlands) |
|
|
|
|
|
|
14:30 |
Best Poster Session
|
|
|
|
|
|
| 14:00 - 15:30 |
Hall IV
|
Forum
3: What is required/minimal criteria/ what should be examined before
prescribing |
Book of abstracts |
|
|
D. Apter (Finland) - A. Glasier (UK) |
IS-57 |
|
|
|
|
| 14:00 - 15:30 |
Club E |
Society
Session 6: Italian Society of Contraception (in English) |
|
|
|
Chair: A. Volpe (Italy) - G.B. Melis (Italy) |
|
|
|
|
Book of abstracts |
|
|
Prevalence of contraceptive use in Italy: comparison
with European countries - G. Benagiano (Italy) |
SS6-01 |
|
|
Contraception without bleeding. Attitude of Italian
women - F. Fruzzetti (Italy) |
SS6-02 |
|
|
Changing contraceptive needs in different life stages
- V. Bruni (Italy) |
SS6-03 |
|
|
Therapeutical effects of hormonal contraceptives -
P.G. Crosignani (Italy) |
SS6-04 |
|
|
|
|
| 15:30 - 16:00 |
Congress Hall |
Keynote
Lecture 3 |
|
|
|
Chair: S. Randall (UK) |
|
|
|
|
|
|
|
New developments in contraception - R. Sitruk-Ware
(USA) |
|
|
|
|
|
